NEPC LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,500
Closed -$125K 55
2023
Q2
$125K Buy
+1,500
New +$125K 0.01% 35
2021
Q3
Sell
-4,500
Closed -$609K 69
2021
Q2
$609K Buy
+4,500
New +$592K 0.09% 59

Other funds holding XBI

NEPC LLC's XBI Position: Q3 2023 in Review

NEPC LLC sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2023, closing a stake of 1,500 shares — an estimated $125K sold.

NEPC LLC first reported a position in XBI in Q2 2021 and held it in 2 quarters. The position peaked at $609K in Q2 2021. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

  • NEPC LLC reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2023 after selling out during the quarter.
  • NEPC LLC sold 1,500 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $125K.
  • NEPC LLC first reported a position in State Street SPDR S&P Biotech ETF in Q2 2021 and held it in 2 quarters.
  • NEPC LLC's State Street SPDR S&P Biotech ETF position peaked at $609K in Q2 2021.
  • 679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on NEPC LLC's 13F filing for Q3 2023, filed 8 Mar 2024.